vTv Therapeutics Inc. Made Big Gain
Wed, Nov 29, 2023 at 07:45 PM
vTv Therapeutics Inc. (VTVT:NASDAQ) rocketted at $14.87, a gain of 55.9%. On Wed, Nov 29, 2023, VTVT:NASDAQ hit a New 2-Week High of $14.87. The stock appeared on our News Catalysts scanner on Thu, Nov 09, 2023 at 05:51 PM in the 'INVESTOR UPDATE' category. From Wed, Nov 15, 2023, the stock recorded 55.56% Up Days and 50.00% Green Days
About vTv Therapeutics Inc. (VTVT:NASDAQ)
vTv Therapeutics Inc is a biopharmaceutical company engaged in drug discovery and development. Its therapies are intended to treat diseases such as Alzheimer's and type-II diabetes.
Top 10 Gainers:
- Vivos Therapeutics Inc. (VVOS:NASDAQ), 831.82%
- Unico American Corporation (UNAM:NASDAQ), 354.55%
- Altamira Therapeutics Ltd. (CYTO:NASDAQ), 180.22%
- PROOF Acquisition Corp I Class A (PACI:NYSE), 148.32%
- Yoshiharu Global Co. (YOSH:NASDAQ), 93.11%
- Conduit Pharmaceuticals Inc Com (CDT:NASDAQ), 72.88%
- Republic First Bancorp, Inc. (FRBK:NASDAQ), 65.19%
- Envoy Med Inc Cl A (COCH:NASDAQ), 55.93%
- vTv Therapeutics Inc. (VTVT:NASDAQ), 55.87%
- Statera Biopharma Inc. (STAB:NASDAQ), 50%